In accordance
with 5 CFR 1320, the information collection is approved for a
period of 18 months. However, upon resubmission, the agency should
report to OMB on progress made toward implementing GPEA
requirements and, if appropriate, provide an explanation as to why
it would be inappropriate or inefficient to provide a fully
electronic (paperless) option to respondents.
Inventory as of this Action
Requested
Previously Approved
10/31/2002
10/31/2002
06/30/2001
1,114
0
1,197
557
0
599
65,000
0
0
Practitioners who dispense narcotic
drugs to individual for maintenance or detoxification treatment
must register with the DEA under the Narcotic Addict Treatment Act
of 1974. Registration is needed for control measures and is used to
prevent diversion.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.